Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
29
NIKA Quote, Financials, Valuation and Earnings
Last price:
$0.69
Seasonality move
:
-1%
Day range:
$0.69 - $0.69
52-week range:
$0.18 - $1.00
Dividend yield:
0%
P/E ratio:
34,500.00x
P/S ratio:
--
P/B ratio:
--
Volume:
100
Avg. volume:
124
1-year change:
35.83%
Market cap:
$708.2M
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nika Pharmaceuticals has -- downside to fair value with a price target of -- per share.
NIKA vs. S&P 500
-
Over the past 5 trading days, Nika Pharmaceuticals has underperformed the S&P 500 by -0.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Nika Pharmaceuticals does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nika Pharmaceuticals has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Nika Pharmaceuticals reported revenues of $160.
Earnings Growth
-
Nika Pharmaceuticals has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nika Pharmaceuticals reported earnings per share of --.
Enterprise value:
708.2M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-10,463.83x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-35128.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$3.2M | -$91.2K | -$88.6K | -$46K | -$13K | |
| EBITDA | -$3.2M | -$91.2K | -$88.6K | -$46K | -$13K | |
| Diluted EPS | -$0.00 | -$0.00 | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4K | $80 | $4.5K | $41.5K | $35K | |
| Total Assets | $1.4K | $80 | $4.5K | $41.5K | $35K | |
| Current Liabilities | -- | -- | $41.4K | $266K | $269.2K | |
| Total Liabilities | $16K | -- | $41.4K | $266K | $269.2K | |
| Total Equity | -$14.7K | $80 | -$36.9K | -$224.5K | -$234.2K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$47K | -$129.6K | -$67.7K | -$84.4K | -$13K | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $51.3K | $159.4K | $68.4K | $99K | $30K | |
| Free Cash Flow | -$47K | -$129.6K | -$67.7K | -$84.3K | -$12.9K | |
NIKA
Sector
Market Cap
$708.2M
$34.4M
Price % of 52-Week High
69%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
35.83%
-37.36%
Beta (5-Year)
--
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.67
200-day SMA
Sell
Level
$0.74
Bollinger Bands (100)
Sell
Level
0.7 - 1.02
Chaikin Money Flow
Sell
Level
-1.8K
20-day SMA
Buy
Level
$0.68
Relative Strength Index (RSI14)
Buy
Level
50.26
ADX Line
Sell
Level
13.78
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$0.72
MACD (12, 26)
Buy
Level
0.16
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-1.7K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nika Pharmaceuticals Inc is a company involved in development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. It has acquired the exclusive rights for production and distribution of the dietary supplements Physiolong and Carotilen, as well as the drug TNG, which has been clinically tested on AIDS patients.
Stock Forecast FAQ
In the current month, NIKA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NIKA average analyst price target in the past 3 months is --.
-
Where Will Nika Pharmaceuticals Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nika Pharmaceuticals share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Nika Pharmaceuticals?
Analysts are divided on their view about Nika Pharmaceuticals share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nika Pharmaceuticals is a Sell and believe this share price will rise from its current level to --.
-
What Is Nika Pharmaceuticals's Price Target?
The price target for Nika Pharmaceuticals over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NIKA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nika Pharmaceuticals is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NIKA?
You can purchase shares of Nika Pharmaceuticals via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nika Pharmaceuticals shares.
-
What Is The Nika Pharmaceuticals Share Price Today?
Nika Pharmaceuticals was last trading at $0.69 per share. This represents the most recent stock quote for Nika Pharmaceuticals. Yesterday, Nika Pharmaceuticals closed at $0.69 per share.
-
How To Buy Nika Pharmaceuticals Stock Online?
In order to purchase Nika Pharmaceuticals stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
